Professional
Added to YB: 2026-03-23
Pitch date: 2026-03-19
VREOF [neutral]
Vireo Growth Inc.
-1.79%
current return
Author Info
Mindset Value provides deep dive research into publicly traded stocks, business models, and ideas. Sign up for the newsletter.
Company Info
Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.
Market Cap
CAD 472.7M
Pitch Price
CAD 0.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
29.16
P/E
-3.65
EV/Sales
3.06
Sector
Pharmaceuticals
Category
growth
A Vireo Strong Quarter
VREOF (earnings): Q4 rev $105M (+25% pro forma), beat est by 10%+, 11.3% same-store sales growth. Outperformed in mature markets: NV +12% vs market +2%, MO +7% vs +2%. 4 acquisitions pending could add $400M+ rev at <5x EBITDA, targeting $800-900M total rev (top 5 globally). MN facility near completion, supply-constrained for years. $100M+ cash. Stock trades 4-5x EBITDA despite double-digit growth trajectory.
Read full article (3 min)